Biocompatible structure, and fabricating methods and applications of same

Patent metadata

Field	Value
Publication number	US-2022401218-A1
Application number	US-202217893273-A
Country	US
Kind code	A1
Filing date	Aug 23, 2022
Priority date	Dec 7, 2016
Publication date	Dec 22, 2022
Grant date	—

Abstract

A biocompatible structure includes a scaffold obtained from a 3D structure. The 3D structure includes base layered structures, each of which includes at least a first layer and a second layer surrounded by the first layer. The first layer includes at least one of first, second and third media. The second layer includes at least another of the first, second and third media. The first medium comprises bone particles. The second medium comprises a polymer dissolvable in a first solvent. The third medium comprises solid particulates dissolvable in a second solvent different than the first solvent. The 3D structure is treated with the second solvent to dissolve the solid particulates so as to form pores at positions of the solid particulates therein, thereby resulting in the scaffold having a porosity adjustable by sizes of the solid particulates and concentration of the solid particulates in the 3D structure.

First claim

What is claimed is:

1 . A biocompatible structure useable for tissue regeneration, comprising:
a scaffold by treating a three-dimensional (3D) structure, the 3D structure comprising one or more base layered structures, wherein each base layered structure comprises at least a first layer and a second layer surrounded by the first layer, wherein the first layer and the second layer are formed of different materials, the first layer comprises at least one of a first medium, a second medium and a third medium, and the second layer comprises at least another of the first medium, the second medium and the third medium; wherein the first medium comprises bone particles, the second medium comprises a polymer that is dissolvable or removable in a first solvent, and the third medium comprises solid particulates alone or in polymeric structures that are dissolvable or removable in a second solvent different than the first solvent, wherein the 3D structure is treated with the second solvent to dissolve the solid particulates of the second medium therefrom so as to remove the solid particulates from the 3D structure and form pores at positions of the solid particulates therein, thereby resulting in the scaffold having a porosity that is adjustable by sizes of the solid particulates and concentration of the solid particulates in the 3D structure.

2 . The biocompatible structure of claim 1 ,
wherein the first layer comprises the first medium and the second medium, and the second layer comprises the third medium; or wherein the first layer comprises the first medium and the third medium, and the second layer comprises the second medium; or wherein the first layer comprises the second medium and the third medium, and the second layer comprises the first medium; or wherein the first layer comprises the first medium, and the second layer comprises the second medium and the third medium; or wherein the first layer comprises the second medium, and the second layer comprises the first medium and the third medium.

3 . The biocompatible structure of claim 1 , wherein the first layer comprises the second medium, and the second layer comprises the third medium.

4 . The biocompatible structure of claim 3 , wherein each base layered structure further comprises a third layer comprising the first medium deposited on the first layer.

5 . The biocompatible structure of claim 1 , wherein the 3D structure comprises a plurality of base layered structures attached to each other horizontally and/or vertically.

6 . The biocompatible structure of claim 5 , wherein the scaffold contains no polymer columns horizontally and/or vertically.

7 . The biocompatible structure of claim 1 , wherein the first medium and the second medium are arranged in layers with the second medium arranged in horizontal or vertical geometries.

8 . The biocompatible structure of claim 1 , wherein the first medium and the second medium arranged in alternating layers with the second medium arranged in horizontal and vertical geometries and the first medium disposed to separate the second medium horizontally and vertically.

9 . The biocompatible structure of claim 1 , wherein the second medium is deposited in a pattern including a continuous u-shaped line that has a repeatable pattern having a first half circle, a first straight line connected to the first half circle and a second half circle opposed to the first half circle and a second straight line connected to the second half circle, two said continuous u-shaped lines being aligned orthogonally to each other, a plurality of irregular circular shapes, a plurality of horizontal lines and a plurality of vertical lines aligned to each other to form a plurality of square shapes, a first plurality of lines and a second plurality of lines aligned to each other to form a plurality of quadrilateral shapes, or a plurality of hexagonal shapes.

10 . The biocompatible structure of claim 1 , wherein the bone particles comprise human bone particles, animal bone particles, and/or artificial bone particles.

11 . The biocompatible structure of claim 1 , wherein the bone particles have sizes in a range between 1 nm to 100 mm.

12 . The biocompatible structure of claim 1 , wherein the polymer is a natural or synthetic biocompatible and/or biodegradable polymer.

13 . The biocompatible structure of claim 1 , wherein the third medium comprises solid particulates that dissolve when immersed in liquid or gaseous solvent environments or based on temperature differentials and that do not immediately interact with the first medium and the second medium.

14 . The biocompatible structure of claim 1 , wherein the third medium is a single or a mixture of rapidly dissolving polymers in a solvent that immediately interacts with the first medium and the second medium.

15 . The biocompatible structure of claim 1 , wherein the third medium is a single rapidly dissolving polymer or a mixture of rapidly dissolving polymers in a solvent that does not immediately interact with the first medium and the second medium.

16 . The biocompatible structure of claim 1 , further comprising at least a fourth medium, and wherein the at least fourth medium material is a polymer with a faster or longer bio-degradation time in a biological system compared to the second medium.

17 . The biocompatible structure of claim 16 , wherein the at least fourth medium materials are loaded with a variety of solid particulates similar to the second medium or the third medium in weight ratios varying from 0.01 to 99.99 wt. %.

18 . The biocompatible structure of claim 16 , wherein each of the second medium, the third medium and the at least fourth medium has degradation rates ranging from 1 second to 100 months.

19 . The biocompatible structure of claim 16 wherein the at least fourth medium is independent or along with the second medium and is deposited in equal or variable ratios compared to the second medium.

20 . The biocompatible structure of claim 16 , wherein the at least one fourth medium is deposited in equal or variable ratios compared to the second medium.

21 . The biocompatible structure of claim 16 , wherein the second medium, the third medium and the at least fourth medium are deposited by a variety of methods that comprises electro-spraying, air deposition, bio-printing, extrusion, poring and curtain polymer deposition.

22 . The biocompatible structure of claim 1 , wherein the porosity of the scaffold is controlled by the deposition parameters, density of component materials and packing; the pores is between 0.1 nm to 3 mm, and the porosity of the scaffold varies from 1 to 99%.

23 . The biocompatible structure of claim 1 , wherein the scaffold is loaded with a plurality of cells, a plurality of drugs, or a plurality of growth factors.

24 . The biocompatible structure of claim 1 , wherein the scaffold is exposed to a gas plasma or corona discharge process in order to induce surface charges of positive, neutral, or negative polarity so as to increase the roughness of the surface morphology and introduce atoms and functional groups onto the surface.

25 . The biocompatible structure of claim 1 , wherein the scaffold is designed to have a non-uniform density and packing density.

26 . The biocompatible structure of claim 1 , wherein construction of the scaffold is done by using 3D bio-printing and hybrid printing technology by la

Assignees

• Univ Arkansas

Inventors

• Alghazali Karrer M
• Saini Viney
• Nima Zeid A
• Biris Alexandru S
• Bourdo Shawn E

Classifications

• B33Y10/00

  Processes of additive manufacturing · CPC title

• B33Y80/00

  Products made by additive manufacturing · CPC title

• A61F2310/00359

  Bone or bony tissue · CPC title

• B33Y40/20

  Post-treatment, e.g. curing, coating or polishing · CPC title

• B29C64/106

  using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material · CPC title